Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 162 (1) , 99-107
- https://doi.org/10.1016/j.bbr.2005.03.010
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2Behavioural Pharmacology, 2004
- Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in ratsPsychopharmacology, 2003
- Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus mazePharmacology Biochemistry and Behavior, 2002
- Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditionsBehavioural Brain Research, 2002
- Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experienceBrain Research, 2002
- Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-mazePharmacology Biochemistry and Behavior, 2002
- Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptorNeuroscience & Biobehavioral Reviews, 2001
- Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxietyBehavioural Brain Research, 2000
- The efferent projections of the periaqueductal gray in the rat: A Phaseolus vulgaris‐leucoagglutinin study. I. Ascending projectionsJournal of Comparative Neurology, 1995
- Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?Trends in Neurosciences, 1994